This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: National Research Council of Canada. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: John Francis Kelly: Innovator in Glycan Research
Introduction
John Francis Kelly is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of glycan research, particularly in relation to Campylobacter infections. His work has implications for both human and animal health, showcasing the importance of innovative solutions in combating pathogens.
Latest Patents
John Francis Kelly holds a patent for "Campylobacter glycans and glycopeptides." This invention addresses the common glycan moiety shared by multiple strains and species of Campylobacter, which is present in various surface-exposed glycoproteins. The glycan has a specific formula: GalNAc-a1, 4-GalNAc-a1,4-[Glc-β1,3]GalNAc-a1,4-GalNAc-a1,4-GalNAc-a1,3-Bac, where Bac is 2, 4-diacetamido-2,4,6-trideoxy-D-glucopyranose. This glycan, along with its immunologically active fragments, can be utilized as vaccines against Campylobacter infections in humans and animals. Additionally, antibodies that specifically bind these compounds may be developed to prevent or neutralize infections in livestock, thereby protecting the human food chain. The glycan can also be linked to one or more amino acids to form a glycopeptide. A method for determining the glycan structure of an intact glycoprotein involves high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS-NMR) spectroscopy.
Career Highlights
John Francis Kelly is affiliated with the National Research Council of Canada, where he conducts his research. His work is pivotal in advancing the understanding of glycan structures and their applications in vaccine development.
Collaborations
He has collaborated with notable colleagues, including David C. Watson and Harold C. Jarrell, contributing to a rich environment of innovation and research.
Conclusion
John Francis Kelly's contributions to glycan research and vaccine development highlight the critical role of inventors in addressing public health challenges. His innovative work continues to pave the way for advancements in the prevention of Campylobacter infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile